Market Tracker

04/27 6:44am ET

NewLink Genetics Corp (NASDAQ:NLNK)

52.10
Delayed Data
As of Apr 24
 -0.90 / -1.70%
Today’s Change
17.32
Today|||52-Week Range
58.73
+31.07%
Year-to-Date

Today’s Trading

Previous close53.00
Today’s open52.74
Day’s range-- - --
Volume390,774
Average volume (3 months)548,430
Market cap$1.5B
Dividend yield--
Data as of 04/24/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-157.83%
Earnings growth (next 5 years)--
Revenue growth (last year)+15,690.67%
P/E ratio15.7
Price/Sales6.41
Price/Book7.15

Competitors

 Today’s
change
Today’s
% change
FWPForward Pharma A/S-0.06-0.19%
MACKMerrimack Pharmaceut...-0.25-1.83%
TTPHTetraphase Pharmaceu...-0.67-1.65%
INSMInsmed Inc-0.21-0.90%
Data as of 04/24/2015

Financials

Next reporting dateMay 5, 2015
EPS forecast (this quarter)-$0.30
Annual revenue (last year)$172.6M
Annual profit (last year)$102.9M
Net profit margin59.60%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive &
Scientific Officer
Charles J. Link
President &
Chief Medical Officer
Nicholas N. Vahanian
Corporate headquarters
Ames, Iowa

Forecasts